Paper19248751
The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence.
Eyre DR and 1 other. Osteoarthritis Cartilage, 2009. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. The Helix-II epitope: a cautionary tale from a cartilage biomarker based on an invalid collagen sequence. Papers, record 19248751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19248751
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cartilage, Articular | Major topic |
| Collagen Type II | Major topic |
| Amino Acid Sequence | |
| Artifacts | |
| Biomarkers | |
| Databases, Protein | |
| Epitopes | |
| Humans | |
| Molecular Sequence Data | |
| Tandem Mass Spectrometry |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AR37318 | NIAMS NIH HHS | United States | R01AR037318 | PubMed and NIH | NIH RePORTER |
| R01 AR036794 | NIAMS NIH HHS | United States | R01AR036794 | PubMed and NIH | NIH RePORTER |
| R01 AR037318 | NIAMS NIH HHS | United States | R01AR037318 | PubMed and NIH | NIH RePORTER |
| R37 AR036794 | NIAMS NIH HHS | United States | R01AR036794 | PubMed and NIH | NIH RePORTER |
| R37 AR037318 | NIAMS NIH HHS | United States | R01AR037318 | PubMed and NIH | NIH RePORTER |
| AR36794 | NIAMS NIH HHS | United States | R01AR036794 | PubMed and NIH | NIH RePORTER |
| R37AR036794 | NIH | NIH RePORTER | |||
| R37AR037318 | NIH | NIH RePORTER |
References11
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15818703 | Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. | Arthritis Rheum | 2005 | https://conductscience.org/library/papers/15818703 | PubMed |
| 2 | 2587267 | Nucleotide sequence of the full length cDNA encoding for human type II procollagen. | Nucleic Acids Res | 1989 | https://conductscience.org/library/papers/2587267 | PubMed |
| 3 | 18203315 | Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy. | J Rheumatol | 2008 | https://conductscience.org/library/papers/18203315 | PubMed |
| 4 | 16569684 | Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis. | Ann Rheum Dis | 2006 | https://conductscience.org/library/papers/16569684 | PubMed |
| 5 | 18403221 | The type II collagen fragments Helix-II and CTX-II reveal different enzymatic pathways of human cartilage collagen degradation. | Osteoarthritis Cartilage | 2008 | https://conductscience.org/library/papers/18403221 | PubMed |
| 6 | 19690637 | Collagen biomarkers for arthritis applications. | Biomark Insights | 2007 | https://conductscience.org/library/papers/19690637 | PubMed |
| 7 | 11350852 | Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. | Ann Rheum Dis | 2001 | https://conductscience.org/library/papers/11350852 | PubMed |
| 8 | 17083085 | Articular cartilage collagen: an irreplaceable framework? | Eur Cell Mater | 2006 | https://conductscience.org/library/papers/17083085 | PubMed |
| 9 | 18434215 | PIIANP and HELIXII diurnal variation. | Osteoarthritis Cartilage | 2008 | https://conductscience.org/library/papers/18434215 | PubMed |
| 10 | 18672194 | Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. | J Card Fail | 2008 | https://conductscience.org/library/papers/18672194 | PubMed |
| 11 | 20527083 | The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover. | Arthritis Res Ther | 2009 | https://conductscience.org/library/papers/20527083 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39114418 | Inflammatory biomarkers and state of the tibiofemoral joint in the osteoarthritic knee: a narrative review. | Ann Jt | 2024 | https://conductscience.org/library/papers/39114418 | PubMed |
| 34616494 | Soluble biological markers in osteoarthritis. | Ther Adv Musculoskelet Dis | 2021 | https://conductscience.org/library/papers/34616494 | PubMed |
| 26417696 | Aspartic acid racemization reveals a high turnover state in knee compared with hip osteoarthritic cartilage. | Osteoarthritis Cartilage | 2016 | https://conductscience.org/library/papers/26417696 | PubMed |
| 25179281 | Chopping off the chondrocyte proteome. | Biomarkers | 2015 | https://conductscience.org/library/papers/25179281 | PubMed |
| 21539724 | Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities. | Arthritis Res Ther | 2011 | https://conductscience.org/library/papers/21539724 | PubMed |
| 21396468 | Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. | Osteoarthritis Cartilage | 2011 | https://conductscience.org/library/papers/21396468 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COL1A1 | 1277 | PubTator's text mining | https://conductscience.org/library/genes/1277 | NCBI Gene |
| COL1A2 | 1278 | PubTator's text mining | https://conductscience.org/library/genes/1278 | NCBI Gene |
| COL2A1 | 1280 | PubTator's text mining | https://conductscience.org/library/genes/1280 | NCBI Gene |
| COL3A1 | 1281 | PubTator's text mining | https://conductscience.org/library/genes/1281 | NCBI Gene |
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| GTS | 2973 | PubTator's text mining | https://conductscience.org/library/genes/2973 | NCBI Gene |
| GYPA | 2993 | PubTator's text mining | https://conductscience.org/library/genes/2993 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19248751
GET https://conductscience.org/api/papers/v1/19248751/authors